Recombinant Human STX4 Protein, N-His

Description of Recombinant Human STX4 Protein, N-His

Introduction: Recombinant human STX4 protein, also known as Syntaxin 4, is a membrane-associated protein that plays a crucial role in the process of membrane fusion. It is involved in various cellular processes such as vesicle trafficking, exocytosis, and cell signaling. Recombinant STX4 protein is produced through recombinant DNA technology, making it a valuable tool for research and therapeutic applications. Structure: The STX4 protein is a member of the syntaxin family, which consists of 35-40 kDa proteins that are characterized by the presence of a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) domain. This domain allows STX4 to interact with other SNARE proteins and participate in membrane fusion events. The protein has a single transmembrane domain and a cytoplasmic C-terminal domain, which contains the SNARE motif. The N-terminal domain of STX4 is responsible for its interaction with other proteins and plays a critical role in its function. Activity: STX4 is primarily involved in the regulation of vesicle trafficking and exocytosis, which are essential processes for the proper functioning of cells. It is responsible for the fusion of vesicles with the plasma membrane, allowing the release of their contents into the extracellular space. STX4 is also involved in the fusion of vesicles with other intracellular compartments, such as lysosomes and endosomes. This protein plays a crucial role in the secretion of hormones, neurotransmitters, and other signaling molecules, making it essential for various physiological processes. Application: Recombinant STX4 protein has numerous applications in both research and therapeutic settings. It is commonly used as an antigen in studies that aim to understand the role of STX4 in various cellular processes. The recombinant protein is also used to generate antibodies that can be used for immunoprecipitation and immunofluorescence experiments. These techniques allow researchers to study the localization and function of STX4 in different cell types and under various conditions. Additionally, recombinant STX4 protein is used in drug discovery and development. As STX4 plays a crucial role in exocytosis, it has been identified as a potential therapeutic target for diseases such as diabetes and neurological disorders. Recombinant STX4 protein can be used to screen for small molecule inhibitors that can modulate its activity, thus providing a potential treatment option for these diseases. Furthermore, recombinant STX4 protein has been used in the development of diagnostic assays for various diseases. As STX4 is involved in vesicle trafficking and exocytosis, its expression and function can be altered in certain diseases. Therefore, measuring the levels of STX4 in patient samples can serve as a diagnostic marker for these conditions. Conclusion: Recombinant human STX4 protein is a valuable tool for scientific research and has numerous potential applications in the fields of drug discovery, diagnostics, and therapeutics. Its structure and activity make it a key player in vesicle trafficking and exocytosis, making it essential for proper cellular function. As research on STX4 continues, the potential for its use in various applications is likely to increase, making it an important protein in the field of biology.